Stock Information
Stoke Therapeutics Inc (STOK)
Ticker Symbol: STOK
Exchange: NASDAQ
Sector: N/A
Market Cap: $1,800.10 mil
Piotroski score: 4
PE Ratio: 49.3961
EPS (TTM): 0.6683
Revenue (TTM): $3.51 M
Dividend Yield: N/A%
ROE: 13.44%
Latest News
-
Forecasting The Future: 5 Analyst Projections For Stoke Therapeutics
Tue, Feb 24, 2026 9:01 AM
-
Wolfe Research Initiates Coverage On Stoke Therapeutics with Outperform Rating, Announces Price Target of $40
Tue, Feb 24, 2026 8:22 AM
Key Financials
Financial data not available